Literature DB >> 19053267

Bimodal recognition of DNA geometry by human topoisomerase II alpha: preferential relaxation of positively supercoiled DNA requires elements in the C-terminal domain.

A Kathleen McClendon1, Amanda C Gentry, Jennifer S Dickey, Marie Brinch, Simon Bendsen, Anni H Andersen, Neil Osheroff.   

Abstract

Human topoisomerase IIalpha, but not topoisomerase IIbeta, can sense the geometry of DNA during relaxation and removes positive supercoils >10-fold faster than it does negative superhelical twists. In contrast, both isoforms maintain lower levels of DNA cleavage intermediates with positively supercoiled substrates. Since topoisomerase IIalpha and IIbeta differ primarily in their C-terminal domains (CTD), this portion of the protein may play a role in sensing DNA geometry. Therefore, to more fully assess the importance of the topoisomerase IIalpha CTD in the recognition of DNA topology, hTop2alphaDelta1175, a mutant human enzyme that lacks its CTD, was examined. The mutant enzyme relaxed negative and positive supercoils at similar rates but still maintained lower levels of cleavage complexes with positively supercoiled DNA. Furthermore, when the CTD of topoisomerase IIbeta was replaced with that of the alpha isoform, the resulting enzyme preferentially relaxed positively supercoiled substrates. In contrast, a chimeric topoisomerase IIalpha that carried the CTD of the beta isoform lost its ability to recognize the geometry of DNA supercoils during relaxation. These findings demonstrate that human topoisomerase IIalpha recognizes DNA geometry in a bimodal fashion, with the ability to preferentially relax positive DNA supercoils residing in the CTD. Finally, results with a series of human topoisomerase IIalpha mutants suggest that clusters of positively charged amino acid residues in the CTD are required for the enzyme to distinguish supercoil geometry during DNA relaxation and that deletion of even the most C-terminal cluster abrogates this recognition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19053267      PMCID: PMC2629653          DOI: 10.1021/bi800453h

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  52 in total

Review 1.  Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice.

Authors:  J M Fortune; N Osheroff
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2000

2.  Analysis of topoisomerase function in bacterial replication fork movement: use of DNA microarrays.

Authors:  A B Khodursky; B J Peter; M B Schmid; J DeRisi; D Botstein; P O Brown; N R Cozzarelli
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

3.  Topoisomerase II from Chlorella virus PBCV-1. Characterization of the smallest known type II topoisomerase.

Authors:  O V Lavrukhin; J M Fortune; T G Wood; D E Burbank; J L Van Etten; N Osheroff; R S Lloyd
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

4.  The geometry of DNA supercoils modulates topoisomerase-mediated DNA cleavage and enzyme response to anticancer drugs.

Authors:  A Kathleen McClendon; Neil Osheroff
Journal:  Biochemistry       Date:  2006-03-07       Impact factor: 3.162

5.  Human topoisomerase IIalpha rapidly relaxes positively supercoiled DNA: implications for enzyme action ahead of replication forks.

Authors:  A Kathleen McClendon; A Chapin Rodriguez; Neil Osheroff
Journal:  J Biol Chem       Date:  2005-09-27       Impact factor: 5.157

6.  Ability of viral topoisomerase II to discern the handedness of supercoiled DNA: bimodal recognition of DNA geometry by type II enzymes.

Authors:  A Kathleen McClendon; Jennifer S Dickey; Neil Osheroff
Journal:  Biochemistry       Date:  2006-09-26       Impact factor: 3.162

Review 7.  DNA topoisomerase II, genotoxicity, and cancer.

Authors:  A Kathleen McClendon; Neil Osheroff
Journal:  Mutat Res       Date:  2007-07-03       Impact factor: 2.433

8.  Antitumour drugs impede DNA uncoiling by topoisomerase I.

Authors:  Daniel A Koster; Komaraiah Palle; Elisa S M Bot; Mary-Ann Bjornsti; Nynke H Dekker
Journal:  Nature       Date:  2007-06-24       Impact factor: 49.962

9.  Top1- and Top2-mediated topological transitions at replication forks ensure fork progression and stability and prevent DNA damage checkpoint activation.

Authors:  Rodrigo Bermejo; Ylli Doksani; Thelma Capra; Yuki-Mori Katou; Hirokazu Tanaka; Katsuhiko Shirahige; Marco Foiani
Journal:  Genes Dev       Date:  2007-08-01       Impact factor: 11.361

10.  C-terminal regions of topoisomerase IIalpha and IIbeta determine isoform-specific functioning of the enzymes in vivo.

Authors:  René M Linka; Andrew C G Porter; Arsen Volkov; Christian Mielke; Fritz Boege; Morten O Christensen
Journal:  Nucleic Acids Res       Date:  2007-05-25       Impact factor: 16.971

View more
  28 in total

1.  Mechanisms of chiral discrimination by topoisomerase IV.

Authors:  K C Neuman; G Charvin; D Bensimon; V Croquette
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

2.  E. coli Gyrase Fails to Negatively Supercoil Diaminopurine-Substituted DNA.

Authors:  Mónica Fernández-Sierra; Qing Shao; Chandler Fountain; Laura Finzi; David Dunlap
Journal:  J Mol Biol       Date:  2015-04-19       Impact factor: 5.469

3.  Interactions between the etoposide derivative F14512 and human type II topoisomerases: implications for the C4 spermine moiety in promoting enzyme-mediated DNA cleavage.

Authors:  Amanda C Gentry; Steven L Pitts; Michael J Jablonsky; Christian Bailly; David E Graves; Neil Osheroff
Journal:  Biochemistry       Date:  2011-03-28       Impact factor: 3.162

Review 4.  The dynamic interplay between DNA topoisomerases and DNA topology.

Authors:  Yeonee Seol; Keir C Neuman
Journal:  Biophys Rev       Date:  2016-11-14

5.  Mechanisms for defining supercoiling set point of DNA gyrase orthologs: I. A nonconserved acidic C-terminal tail modulates Escherichia coli gyrase activity.

Authors:  Elsa M Tretter; James M Berger
Journal:  J Biol Chem       Date:  2012-03-28       Impact factor: 5.157

6.  The tail that wags the dog: topoisomerase IV ParC C-terminal domain controls strand passage activity through multipartite topology-dependent interactions with DNA.

Authors:  Keir C Neuman
Journal:  J Mol Biol       Date:  2013-07-11       Impact factor: 5.469

Review 7.  The use of divalent metal ions by type II topoisomerases.

Authors:  Joseph E Deweese; Neil Osheroff
Journal:  Metallomics       Date:  2010-05-21       Impact factor: 4.526

8.  The Dynamic Interplay Between DNA Topoisomerases and DNA Topology.

Authors:  Yeonee Seol; Keir C Neuman
Journal:  Biophys Rev       Date:  2016-07-02

Review 9.  Topoisomerase II and leukemia.

Authors:  Maryjean Pendleton; R Hunter Lindsey; Carolyn A Felix; David Grimwade; Neil Osheroff
Journal:  Ann N Y Acad Sci       Date:  2014-02-03       Impact factor: 5.691

10.  Chiral discrimination and writhe-dependent relaxation mechanism of human topoisomerase IIα.

Authors:  Yeonee Seol; Amanda C Gentry; Neil Osheroff; Keir C Neuman
Journal:  J Biol Chem       Date:  2013-03-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.